G1 Therapeutics Inc (NASDAQ:GTHX)
| 1.23 Delayed Data As of 3:59pm ET |  -0.04 / -3.15%Today’s Change | 1.22 Today|||52-Week Range 13.85 | -77.35% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $79.7M |
Company Description
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
Contact Information
G1 Therapeutics, Inc. 700 Park Offices Drive Research Triangle Park North Carolina 27709 |
Employees
Shareholders
| Mutual fund holders | 9.61% |
| Individual stakeholders | 27.54% |
| Other institutional | 20.84% |
Top Executives
| Jack Bailey | President, Chief Executive Officer & Director |
| Terry L. Murdock | Chief Operating Officer |
| John Umstead | Chief Financial Officer |
| Rajesh K. Malik | Chief Medical Officer |
| Monica Roberts Thomas | Chief Compliance Officer & General Counsel |
